phenyliminoribitol and Leishmaniasis

phenyliminoribitol has been researched along with Leishmaniasis* in 1 studies

Reviews

1 review(s) available for phenyliminoribitol and Leishmaniasis

ArticleYear
The importance of nucleoside hydrolase enzyme (NH) in studies to treatment of Leishmania: A review.
    Chemico-biological interactions, 2017, Feb-01, Volume: 263

    Leishmania is a genus of trypanosomes, which are responsible for leishmaniasis disease, a major trypanosome infection in humans. In recent years, published studies have shown that the search for new drugs for Leishmania treatments has intensified. Through technique modeling it has been possible to develop new compounds, which act as nucleoside hydrolase (NH) inhibitors. The effect of these enzymes is the hydrolysis of certain RNA nucleotides, which include uridine and inosine, necessary for the protozoa to transform certain nucleosides obtained from infected individuals into nucleobases for the preparation of their DNA. The obtention of NH inhibitors is very important to eliminate leishmaniasis disease in infected individuals. The aim of this study is to discuss the research and development of new agents for the treatment of Leishmania, and to stimulate the formulation of new NH inhibitors.

    Topics: Animals; Catalytic Domain; Enzyme Inhibitors; Humans; Leishmania; Leishmaniasis; Molecular Conformation; Molecular Docking Simulation; N-Glycosyl Hydrolases; Protozoan Proteins; Ribitol

2017